 |
 |

Surgical Management of Carotid Body Tumor
Hushang Javid, MD, PhD;
William S. Dye, MD;
James A. Hunter, MD;
Hassan Najafi, MD;
Ormand C. Julian, MD, PhD
AMA Arch Surg. 1967;95(5):771-779.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
TUMOR of the carotid body, while not common and often benign and asymptomatic, continues to be a subject of great controversy. The confusion regarding indication for surgical intervention probably relates to inadequate knowledge regarding the natural history, incidence of malignancy and the risk of operative mortality and morbidity. The indication for surgical intervention has swung through all extremes in the past few decades. For a number of years complete removal was considered imperative, influenced by the report of Harrington et al1 in 1941, which suggested that 50% of these tumors were histologically malignant. The authors, however, appreciated a more benign clinical course in spite of the morphologic appearance. LeCompte,2 Lahey and Warren,3 Reid,4 and Martin5 advised against removal of the carotid body tumor based on the incidence of high mortality and morbidity. Le-Compte stated that the carotid body tumor almost never gives rise to distant
. . . [Full Text PDF of this Article]
Author Affiliations
Chicago
From the Division of Surgery, University of Illinois College of Medicine, and the Department of Surgery, Presbyterian-St. Luke's Hospital, Chicago.
Footnotes
Submitted for publication July 26, 1967.
Read before the 15th Scientific Meeting of the North American Chapter of the International Cardiovascular Society, Atlantic City, NJ, June 16, 1967.
Reprint requests to Room 504, 1725 W Harrison St, Chicago 60612 (Dr. Javid).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|